Microvesicles and viral infection

Journal of Virology

Volumn 85, Issue 24, 2011, Pages 12844-12854

  Meckes Jr , David G ^a   Raab Traub, Nancy ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL COMMUNICATION; CELL FUNCTION; CELL SPECIFICITY; CELL VACUOLE; EPSTEIN BARR VIRUS; EXOSOME; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; SHORT SURVEY; SIGNAL TRANSDUCTION; VIRUS ASSEMBLY; VIRUS ENTRY; VIRUS INFECTION; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS VIRULENCE;

EXOSOMES; HUMANS; MODELS, BIOLOGICAL; VIRUSES;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4; SIMPLEXVIRUS;

EID: 84855855145     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05853-11     Document Type: Short Survey

References (172)

1. Abid Hussein, M. N., A. N. Boing, A. Sturk, C. M. Hau, and R. Nieuwland. 2007. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb. Haemost. 98:1096-1107.
2. Admyre, C., S. M. Johansson, S. Paulie, and S. Gabrielsson. 2006. Direct exosome stimulation of peripheral human T cells detected by ELISPOT. Eur. J. Immunol. 36:1772-1781.
3. Admyre, C., et al. 2007. Exosomes with immune modulatory features are present in human breast milk. J. Immunol. 179:1969-1978.
4. Ali, S. A., et al. 2010. Genetic characterization of HIV type 1 Nef-induced vesicle secretion. AIDS Res. Hum. Retroviruses 26:173-192.
5. Al-Nedawi, K., B. Meehan, R. S. Kerbel, A. C. Allison, and J. Rak. 2009. Endothelial expression of autocrine VEGF upon the uptake of tumorderived microvesicles containing oncogenic EGFR. Proc. Natl. Acad. Sci. U. S. A. 106:3794-3799.
6. Al-Nedawi, K., et al. 2008. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10:619-624.
7. Alvarez-Erviti, L., et al. 2011. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29:341-345.
8. Andre, F., et al. 2002. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360:295-305.
9. Antonyak, M. A., et al. 2011. Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc. Natl. Acad. Sci. U. S. A. 108:4852-4857.
10. Aurelian, L., and R. R. Wagner. 1966. Two populations of herpes virus virions which appear to differ in physical properties and DNA composition. Proc. Natl. Acad. Sci. U. S. A. 56:902-909.
11. Barreto, A., et al. 2010. Membrane vesicles released by intestinal epithelial cells infected with rotavirus inhibit T-cell function. Viral Immunol. 23:595-608.
12. Bellone, M., et al. 1997. Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. 159:5391-5399.
13. Berckmans, R. J., A. Sturk, L. M. van Tienen, M. C. Schaap, and R. Nieuwland. 2011. Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood 117:3172-3180.
14. Bergsmedh, A., et al. 2001. Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc. Natl. Acad. Sci. U. S. A. 98:6407-6411.
15. Bess, J. W., Jr., R. J. Gorelick, W. J. Bosche, L. E. Henderson, and L. O. Arthur. 1997. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology 230:134-144.
16. Bhella, D., F. J. Rixon, and D. J. Dargan. 2000. Cryomicroscopy of human cytomegalovirus virions reveals more densely packed genomic DNA than in herpes simplex virus type 1. J. Mol. Biol. 295:155-161.
17. Bianco, F., et al. 2009. Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 28:1043-1054.
18. Bieniasz, P. D. 2009. The cell biology of HIV-1 virion genesis. Cell Host. Microbe 5:550-558.
19. Bobrie, A., M. Colombo, G. Raposo, and C. Thery. 6 June 2011. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic. doi: 10.1111/j.1600-0854.2011.01225.x.
20. Booth, A. M., et al. 2006. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J. Cell Biol. 172:923-935.
21. Brugger, B., et al. 2006. The HIV lipidome: a raft with an unusual composition. Proc. Natl. Acad. Sci. U. S. A. 103:2641-2646.
22. Bruss, V. 2007. Hepatitis B virus morphogenesis. World J. Gastroenterol. 13:65-73.
23. Busson, P., et al. 1988. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int. J. Cancer 42:599-606.
24. Campbell, T. D., M. Khan, M. B. Huang, V. C. Bond, and M. D. Powell. 2008. HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions. Ethn. Dis. 18(Suppl. 2):S2-14-9.
25. Camussi, G., M. C. Deregibus, S. Bruno, V. Cantaluppi, and L. Biancone. 2010. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 78:838-848.
26. Cantin, R., J. Diou, D. Belanger, A. M. Tremblay, and C. Gilbert. 2008. Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J. Immunol. Methods 338:21-30.
27. Ceccarelli, S., et al. 2007. Epstein-Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes. Int. J. Cancer 121:1494-1506.
28. Chai, N., et al. 2008. Properties of subviral particles of hepatitis B virus. J. Virol. 82:7812-7817.
29. Chairoungdua, A., D. L. Smith, P. Pochard, M. Hull, and M. J. Caplan. 2010. Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling. J. Cell Biol. 190:1079-1091.
30. Chen, B. J., and R. A. Lamb. 2008. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology 372:221-232.
31. Chertova, E., et al. 2006. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocytederived macrophages. J. Virol. 80:9039-9052.
32. Choi, D. S., et al. 2007. Proteomic analysis of microvesicles derived from human colorectal cancer cells. J. Proteome. Res. 6:4646-4655.
33. Clayton, A., and M. D. Mason. 2009. Exosomes in tumour immunity. Curr. Oncol. 16:46-49.
34. Cocca, B. A., A. M. Cline, and M. Z. Radic. 2002. Blebs and apoptotic bodies are B cell autoantigens. J. Immunol. 169:159-166.
35. Cocucci, E., G. Racchetti, and J. Meldolesi. 2009. Shedding microvesicles: artefacts no more. Trends Cell Biol. 19:43-51.
36. Conde-Vancells, J., et al. 2008. Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J. Proteome Res. 7:5157-5166.
37. Conde-Vancells, J., et al. 2010. Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples. Proteomics Clin. Appl. 4:416-425.
38. Costa, L. J., et al. 2006. Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1. Retrovirology 3:33.
39. Cyrklaff, M., et al. 2005. Cryo-electron tomography of vaccinia virus. Proc. Natl. Acad. Sci. U. S. A. 102:2772-2777.
40. Dargan, D. J., and J. H. Subak-Sharpe. 1997. The effect of herpes simplex virus type 1 L-particles on virus entry, replication, and the infectivity of naked herpesvirus DNA. Virology 239:378-388.
41. de Gassart, A., C. Geminard, B. Fevrier, G. Raposo, and M. Vidal. 2003. Lipid raft-associated protein sorting in exosomes. Blood 102:4336-4344.
42. Del Conde, I., C. N. Shrimpton, P. Thiagarajan, and J. A. Lopez. 2005. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106:1604-1611.
43. Dolo, V., et al. 2005. Shedding of membrane vesicles by tumor and endothelial cells. Ital.J. Anat. Embryol. 110:127-133.
44. Dukers, D. F., et al. 2000. Direct immunosuppressive effects of EBVencoded latent membrane protein 1. J. Immunol. 165:663-670.
45. Dvorak, H. F., et al. 1981. Tumor shedding and coagulation. Science 212:923-924.
46. Escrevente, C., S. Keller, P. Altevogt, and J. Costa. 2011. Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer. 11:108.
47. Fader, C. M., A. Savina, D. Sanchez, and M. I. Colombo. 2005. Exosome secretion and red cell maturation: Exploring molecular components involved in the docking and fusion of multivesicular bodies in K562 cells. Blood Cells Mol. Dis. 35:153-157.
48. Fang, Y., et al. 2007. Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol. 5:e158.
49. Faure, J., et al. 2006. Exosomes are released by cultured cortical neurones. Mol. Cell Neurosci. 31:642-648.
50. Fevrier, B., et al. 2004. Cells release prions in association with exosomes. Proc. Natl. Acad. Sci. U. S. A. 101:9683-9688.
51. Flanagan, J., J. Middeldorp, and T. Sculley. 2003. Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J. Gen. Virol. 84:1871-1879.
52. Gan, X., and S. J. Gould. 2011. Identification of an inhibitory budding signal that blocks the release of HIV particles and exosome/microvesicle proteins. Mol. Biol. Cell 22:817-830.
53. Ganem, D., and A. M. Prince. 2004. Hepatitis B virus infection-natural history and clinical consequences. N. Engl. J. Med. 350:1118-1129.
54. Gastaminza, P., et al. 2010. Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture. J. Virol. 84:10999-11009.
55. Ginestra, A., et al. 1998. The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res. 18:3433-3437.
56. Gluschankof, P., I. Mondor, H. R. Gelderblom, and Q. J. Sattentau. 1997. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. Virology 230:125-133.
57. Gould, S. J., A. M. Booth, and J. E. Hildreth. 2003. The Trojan exosome hypothesis. Proc. Natl. Acad. Sci. U. S. A. 100:10592-10597.
58. Gourzones, C., et al. 2010. Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol. J. 7:271.
59. Graves, L. E., et al. 2004. Proinvasive properties of ovarian cancer ascitesderived membrane vesicles. Cancer Res. 64:7045-7049.
60. Grigorov, B., et al. 2009. A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. Retrovirology. 6:28.
61. Gutwein, P., et al. 2005. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin. Cancer Res. 11:2492-2501.
62. Gyorgy, B., et al. 2011. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol. Life Sci. 68:2667-2688.
63. Harrison, M. S., T. Sakaguchi, and A. P. Schmitt. 2010. Paramyxovirus assembly and budding: building particles that transmit infections. Int. J. Biochem. Cell Biol. 42:1416-1429.
64. Heijnen, H. F., A. E. Schiel, R. Fijnheer, H. J. Geuze, and J. J. Sixma. 1999. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94:3791-3799.
65. Hemler, M. E. 2005. Tetraspanin functions and associated microdomains. Nat. Rev. Mol. Cell Biol. 6:801-811.
66. Higginbotham, J. N., et al. 2011. Amphiregulin exosomes increase cancer cell invasion. Curr. Biol. 21:779-786.
67. Holmgren, L., et al. 1999. Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood 93:3956-3963.
68. Hong, B. S., et al. 2009. Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics 10:556.
69. Hood, J. L., H. Pan, G. M. Lanza, and S. A. Wickline. 2009. Paracrine induction of endothelium by tumor exosomes. Lab Invest. 89:1317-1328.
70. Hood, J. L., R. S. San, and S. A. Wickline. 2011. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 71:3792-3801.
71. Houali, K., et al. 2007. A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin. Cancer Res. 13:4993-5000.
72. Hristov, M., W. Erl, S. Linder, and P. C. Weber. 2004. Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood 104:2761-2766.
73. Hsu, C., et al. 2010. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J. Cell Biol. 189:223-232.
74. Hurley, J. H., E. Boura, L. A. Carlson, and B. Rozycki. 2010. Membrane budding. Cell 143:875-887.
75. Izquierdo-Useros, N., et al. 2009. Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood 113:2732-2741.
76. Janowska-Wieczorek, A., et al. 2001. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 98:3143-3149.
77. Janowska-Wieczorek, A., et al. 2005. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int. J. Cancer 113:752-760.
78. Ji, H., et al. 2008. Difference gel electrophoresis analysis of Ras-transformed fibroblast cell-derived exosomes. Electrophoresis 29:2660-2671.
79. Jolly, C., and Q. J. Sattentau. 2007. Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspaninenriched plasma membrane domains. J. Virol. 81:7873-7884.
80. Jones, D. M., and J. McLauchlan. 2010. Hepatitis C virus: assembly and release of virus particles. J. Biol. Chem. 285:22733-22739.
81. Kalejta, R. F. 2008. Functions of human cytomegalovirus tegument proteins prior to immediate early gene expression. Curr. Top. Microbiol. Immunol. 325:101-115.
82. Kaplan, P. M., E. C. Ford, R. H. Purcell, and J. L. Gerin. 1976. Demonstration of subpopulations of Dane particles. J. Virol. 17:885-893.
83. Kaye, K. M., K. M. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. U. S. A. 90:9150-9154.
84. Keller, S., et al. 2009. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett. 278:73-81.
85. Keller, S., et al. 2007. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int. 72:1095-1102.
86. Kelly, B. J., C. Fraefel, A. L. Cunningham, and R. J. Diefenbach. 2009. Functional roles of the tegument proteins of herpes simplex virus type 1. Virus Res. 145:173-186.
87. Keryer-Bibens, C., et al. 2006. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer 6:283.
88. Kesimer, M., et al. 2009. Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J. 23:1858-1868.
89. Khatua, A. K., H. E. Taylor, J. E. Hildreth, and W. Popik. 2009. Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells. J. Virol. 83:512-521.
90. Kim, H. K., et al. 2003. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur. J. Cancer. 39:184-191.
91. Kleijmeer, M. J., et al. 2001. Antigen loading of MHC class I molecules in the endocytic tract. Traffic 2:124-137.
92. Klibi, J., et al. 2009. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood 113:1957-1966.
93. Lancaster, G. I., and M. A. Febbraio. 2005. Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. J. Biol. Chem. 280:23349-23355.
94. Lee, T. H., et al. 2011. Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris'. Semin. Immunopathol. 33:455-467.
95. Lehmann, B. D., et al. 2008. Senescence-associated exosome release from human prostate cancer cells. Cancer Res. 68:7864-7871.
96. + T cells. Traffic 11:110-122.
97. Logozzi, M., et al. 2009. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One 4:e5219.
98. Loret, S., G. Guay, and R. Lippe. 2008. Comprehensive characterization of extracellular herpes simplex virus type 1 virions. J. Virol. 82:8605-8618.
99. Mack, M., et al. 2000. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat. Med. 6:769-775.
100. Madrid, R., et al. 2005. Nef-induced alteration of the early/recycling endosomal compartment correlates with enhancement of HIV-1 infectivity. J. Biol. Chem. 280:5032-5044.
101. Marsh, M., and A. Helenius. 2006. Virus entry: open sesame. Cell 124:729-740.
102. Masciopinto, F., et al. 2004. Association of hepatitis C virus envelope proteins with exosomes. Eur. J. Immunol. 34:2834-2842.
103. Mathivanan, S., H. Ji, and R. J. Simpson. 2010. Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 73:1907-1920.
104. Mazurov, D., G. Heidecker, and D. Derse. 2006. HTLV-1 Gag protein associates with CD82 tetraspanin microdomains at the plasma membrane. Virology 346:194-204.
105. Mazurov, D., G. Heidecker, and D. Derse. 2007. The inner loop of tetraspanins CD82 and CD81 mediates interactions with human T cell lymphotrophic virus type 1 Gag protein. J. Biol. Chem. 282:3896-3903.
106. McCready, J., J. D. Sims, D. Chan, and D. G. Jay. 2010. Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer 10:294.
107. McLauchlan, J., C. Addison, M. C. Craigie, and F. J. Rixon. 1992. Noninfectious L-particles supply functions which can facilitate infection by HSV-1. Virology 190:682-688.
108. McLauchlan, J., and F. J. Rixon. 1992. Characterization of enveloped tegument structures (L particles) produced by alphaherpesviruses: integrity of the tegument does not depend on the presence of capsid or envelope. J. Gen. Virol. 73:269-276.
109. Mears, R., et al. 2004. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 4:4019-4031.
110. Meckes, D. G., Jr., et al. 2010. Human tumor virus utilizes exosomes for intercellular communication. Proc. Natl. Acad. Sci. U. S. A. 107:20370-20375.
111. Michael, A., et al. 2010. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis. 16:34-38.
112. Morelli, A. E., et al. 2004. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 104:3257-3266.
113. Mori, Y., et al. 2008. Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic 9:1728-1742.
114. Muratori, C., et al. 2009. Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells. Cell Host Microbe 6:218-230.
115. Nguyen, D. G., A. Booth, S. J. Gould, and J. E. Hildreth. 2003. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J. Biol. Chem. 278:52347-52354.
116. Nilsson, J., et al. 2009. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br. J. Cancer 100:1603-1607.
117. Orozco, A. F., et al. 2009. Placental release of distinct DNA-associated micro-particles into maternal circulation: reflective of gestation time and preeclampsia. Placenta 30:891-897.
118. Ostrowski, M., et al. 2010. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 12:19-30.
119. Park, J. E., et al. 2010. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol. Cell Proteomics 9:1085-1099.
120. Pegtel, D. M., et al. 2010. Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. U. S. A. 107:6328-6333.
121. Piccin, A., W. G. Murphy, and O. P. Smith. 2007. Circulating microparticles: pathophysiology and clinical implications. Blood Rev. 21:157-171.
122. Pisitkun, T., R. F. Shen, and M. A. Knepper. 2004. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. U. S. A. 101:13368-13373.
123. Pizzirani, C., et al. 2007. Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood 109:3856-3864.
124. Prado, N., et al. 2008. Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction. J. Immunol. 181:1519-1525.
125. Qu, J. L., et al. 2009. Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig. Liver Dis. 41:875-880.
126. Raimondo, F., L. Morosi, C. Chinello, F. Magni, and M. Pitto. 2011. Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery. Proteomics 11:709-720.
127. Rak, J. 2010. Microparticles in cancer. Semin. Thromb. Hemost. 36:888-906.
128. Raposo, G., et al. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:1161-1172.
129. Rechavi, O., I. Goldstein, and Y. Kloog. 2009. Intercellular exchange of proteins: the immune cell habit of sharing. FEBS Lett. 583:1792-1799.
130. Rixon, F. J., C. Addison, and J. McLauchlan. 1992. Assembly of enveloped tegument structures (L particles) can occur independently of virion maturation in herpes simplex virus type 1-infected cells. J. Gen. Virol. 73:277-284.
131. Rossman, J. S., and R. A. Lamb. 2011. Influenza virus assembly and budding. Virology 411:229-236.
132. Rozmyslowicz, T., et al. 2003. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS 17:33-42.
133. Sanfridson, A., S. Hester, and C. Doyle. 1997. Nef proteins encoded by human and simian immunodeficiency viruses induce the accumulation of endosomes and lysosomes in human T cells. Proc. Natl. Acad. Sci. U. S. A. 94:873-878.
134. Sato, K., et al. 2008. Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins. J. Virol. 82:1021-1033.
135. Schiera, G., et al. 2007. Neurons produce FGF2 and VEGF and secrete them at least in part by shedding extracellular vesicles. J. Cell Mol. Med. 11:1384-1394.
136. Shen, B., N. Wu, J. M. Yang, and S. J. Gould. 2011. Protein targeting to exosomes/microvesicles by plasma membrane anchors. J. Biol. Chem. 286:14383-14395.
137. Simons, M., and G. Raposo. 2009. Exosomes-vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 21:575-581.
138. Skog, J., T. Wurdinger, R. S. van, et al. 2008. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10:1470-1476.
139. Skokos, D., et al. 2001. Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J. Immunol. 166:868-876.
140. Spehner, D., and R. Drillien. 2008. Extracellular vesicles containing virusencoded membrane proteins are a byproduct of infection with modified vaccinia virus Ankara. Virus Res. 137:129-136.
141. Staubach, S., H. Razawi, and F. G. Hanisch. 2009. Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7. Proteomics 9:2820-2835.
142. Stenmark, H. 2009. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 10:513-525.
143. Stoorvogel, W., M. J. Kleijmeer, H. J. Geuze, and G. Raposo. 2002. The biogenesis and functions of exosomes. Traffic 3:321-330.
144. Stumptner-Cuvelette, P., et al. 2003. Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase. Mol. Biol. Cell 14:4857-4870.
145. Sullivan, R., F. Saez, J. Girouard, and G. Frenette. 2005. Role of exosomes in sperm maturation during the transit along the male reproductive tract. Blood Cells Mol. Dis. 35:1-10.
146. Svennerholm, B., et al. 1980. Separation of herpes simplex virus virions and nucleocapsids on Percoll gradients. J. Virol. Methods 1:303-309.
147. Szilagyi, J. F., and J. Berriman. 1994. Herpes simplex virus L particles contain spherical membrane-enclosed inclusion vesicles. J. Gen. Virol. 75:1749-1753.
148. Szilagyi, J. F., and C. Cunningham. 1991. Identification and characterization of a novel non-infectious herpes simplex virus-related particle. J. Gen. Virol. 72:661-668.
149. Tamai, K., et al. 2010. Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein. Biochem. Biophys. Res. Commun. 399:384-390.
150. Taylor, D. D., S. Akyol, and C. Gercel-Taylor. 2006. Pregnancy-associated exosomes and their modulation of T cell signaling. J. Immunol. 176:1534-1542.
151. Taylor, D. D., and C. Gercel-Taylor. 2011. Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Semin. Immunopathol. 33:441-454.
152. Temme, S., A. M. Eis-Hubinger, A. D. McLellan, and N. Koch. 2010. The herpes simplex virus-1 encoded glycoprotein B diverts HLA-DR into the exosome pathway. J. Immunol. 184:236-243.
153. Thery, C., et al. 2001. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166:7309-7318.
154. Thery, C., M. Ostrowski, and E. Segura. 2009. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9:581-593.
155. Trajkovic, K., et al. 2008. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:1244-1247.
156. Trams, E. G., C. J. Lauter, N. Salem, Jr., and U. Heine. 1981. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim. Biophys. Acta 645:63-70.
157. Valadi, H., et al. 2007. Exosome-mediated transfer of mRNAs and micro-RNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9:654-659.
158. Valenti, R., et al. 2006. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res. 66:9290-9298.
159. Vallhov, H., et al. 2011. Exosomes containing glycoprotein 350 released by EBV-transformed B cells selectively target B cells through CD21 and block EBV infection in vitro. J. Immunol. 186:73-82.
160. Vazirabadi, G., T. R. Geiger, W. F. Coffin III, and J. M. Martin. 2003. Epstein-Barr virus latent membrane protein-1 (LMP-1) and lytic LMP-1 localization in plasma membrane-derived extracellular vesicles and intracellular virions. J. Gen. Virol. 84:1997-2008.
161. Verweij, F. J., et al. 2011. LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-kappaB activation. EMBO J. 30:2115-2129.
162. + memory T cells by releasing antigenic exosomes. J. Immunol. 182:1548-1559.
163. Wang, D., D. Liebowitz, and E. Kieff. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
164. Wang, J. J., R. Horton, V. Varthakavi, P. Spearman, and L. Ratner. 1999. Formation and release of virus-like particles by HIV-1 matrix protein. AIDS 13:281-283.
165. Webber, J., R. Steadman, M. D. Mason, Z. Tabi, and A. Clayton. 2010. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res. 70:9621-9630.
166. Wiley, R. D., and S. Gummuluru. 2006. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc. Natl. Acad. Sci. U. S. A. 103:738-743.
167. Williams, R. L., and S. Urbe. 2007. The emerging shape of the ESCRT machinery. Nat. Rev. Mol. Cell Biol. 8:355-368.
168. Wolf, P. 1967. The nature and significance of platelet products in human plasma. Br. J. Haematol. 13:269-288.
169. Wright, H. T., Jr., C. R. Goodheart, and A. Lielausis. 1964. Human cytomegalovirus morphology by negative staining. Virology 23:419-424.
170. Wubbolts, R., et al. 2003. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J. Biol. Chem. 278:10963-10972.
171. Xu, W., et al. 2009. HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat. Immunol. 10:1008-1017.
172. Yanez-Mo, M., O. Barreiro, M. Gordon-Alonso, M. Sala-Valdes, and F. Sanchez-Madrid. 2009. Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol. 19:434-446.